Skip to main content
OpenTrials
Completed

NCT Number: NCT06014099

Research on the Application of Blood Collection Through Midline Catheters of Different Lengths

Therefore, in this study, the investigators propose to use a randomized controlled prospective open study on inpatients with difficult blood collection, by comparing the effects of the application of two types of peripheral venous catheters for blood collection via LPC and MC, with a view to improving the success rate of blood collection in difficult peripheral venous blood collection, and providing a theoretical basis for the later application of long peripheral venous catheters and midline catheters; and providing a basis for optimizing the experience of venous blood collection by nurses.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Linfang Zhao

Hangzhou, Zhejiang, 310000, China

About this study

Using block randomization, patients were randomized in 1:1:1 blocks into experimental arm 1(Long peripheral venous catheter), experimental arm 2(midline catheter), and control (short peripheral venous catheter) with a block length of 6. Patients have a total of 27 blocks, import data into SPSS23, randomly group by SPSS, generate random numbers, and group according to the size of random numbers in each unit group, the largest in the group is assigned to the experimental group 1, the middle of the group is assigned to the experimental group 2, and the smallest in the group is assigned to the control group. The experimental group1 used the LPC for blood collection, the experimental group 2 used the MC for blood collection,and the control group used the Short PIVC for blood collection.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Meet the international diagnostic criteria for metabolic syndrome (such as ATP III criteria or domestic Diabetes Branch of Chinese Medical Association criteria).
  • The estimated treatment time of intravenous infusion is 1-4 weeks, and the nature of the infusion drug meets the indications of LPCs and MCs.
  • Blood samples should be collected more than 3 times during the hospital.

Exclusion criteria

  • A history of radiotherapy, thrombosis, and trauma at the catheter site.
  • Plan to discharge from the hospital with the tube.
  • Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, illiterate, etc.

Treatment and study plan

Long peripheral venous catheters for blood collection

Behavioral

used LPC for blood collection

Midline catheter for blood collection

Behavioral

used MCs for blood collection

SPCs for blood collection

Behavioral

used SPCs for blood collection

Primary outcomes

  1. Success rate of first blood collection

    Time frame: during catheter indwelling,an average of 2 weeks

    Number of successful initial venous blood collection cases as a percentage of the total number of cases in this group

  2. Total success rate of blood collection

    Time frame: during catheter indwelling,an average of 2 weeks

    Number of patients with successful intravenous blood collection as a proportion of the number of cases in this group

Secondary outcomes

  1. Catheter-related complication rate

    Time frame: during catheter indwelling,an average of 2 weeks

    The proportion of patients with complications as a proportion of the total number of cases

  2. Number of days for catheters to linger

    Time frame: during catheter indwelling,an average of 2 weeks

    The number of days between catheter insertion and catheter removal

Sponsors and collaborators

Lead sponsor

Sir Run Run Shaw Hospital

Other

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Aug 28, 2023
Registry last updated
Apr 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.